tirzepatide sydney in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial ๐งฌ New data from the
Description
It previously had indications for the treatment of type 2 diabetes and chronic weight management
Xie J, Wang M, Long Z, Ning H, Li J, Cao Y, Liao Y, Liu G, Wang F, Pan A

If it isnt, we explain the reasoning clearly
Future trials are expected to showcase an even greater weight loss effectiveness for retatrutide due to its unique triple-agonist mechanisms
By addressing insulin resistance, promoting weight loss, and reducing inflammation, tirzepatide has the potential to improve liver health and mitigate the impact of NAFLD

NEJM 2022 FDA Approves New Drug Treatment for Chronic Weight Management (Wegovy) FDA Approves New Medication for Chronic Weight Management (Zepbound) Frias JP et al
